FindTrial
Sign In

A Study to find the Prevalence of Human Papilloma virus (HPV) in Esophageal Squamous Cell Cancers (a type of Food pipe cancers) and its impact on the Staging and Management of these cancers

Prevalence of Human Papilloma Virus in Esophageal Squamous Cell Cancers and its Impact on Staging and Management: A Prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/026217
Enrollment
50
Registered
2020-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified

Interventions

None listed

Sponsors

All India Institute of Medical Sciences Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Primary Oesophageal Squamous cell carcinoma proven by histopathology

Exclusion criteria

Exclusion criteria: Recurrent Cancers Patients with significant comorbidities which preclude full participation in the study

Design outcomes

Primary

MeasureTime frame
HPV positivity as measured by Polymerase Chain Reaction (PCR) and p16 Immunohistochemistry on tissue biopsy samplesTimepoint: At the time of diagnosis by endoscopic biopsy—

Secondary

MeasureTime frame
All Cause MortalityTimepoint: 3 years;Compare Stage at Presentation between HPV positive and Negative TumoursTimepoint: At the time of Diagnosis (after staging investigations);Correlation between HPV positivity by PCR and p16 IHC PositivityTimepoint: At the time of diagnosis by endoscopic biopsy—

Countries

India

Contacts

Public ContactRajkumar Kottayasamy Seenivasagam

All India Institute of Medical Sciences Rishikesh

drksrajkumar@gmail.com9940155250

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026